300858 科拓生物
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资24,5827.82%22,8002,3352,0182,016
投资性房地产0--0000
固定资产363,699-2.04%371,284372,861207,055197,548
在建工程528,7375.14%502,865172,069156,65238,739
无形资产59,420-1.13%60,10248,32651,05953,045
商誉1,9130.00%1,9131,9131,9131,913
其他非流动资产128,33355.36%82,606363,388435,853171,431
1,106,6846.25%1,041,571960,893854,550464,692

流动资产
货币资金209,112109.75%99,696108,635191,596875,358
应收账款78,74914.02%69,06556,47465,395103,266
存货38,303-17.57%46,46646,59939,22350,933
其他流动资产594,460-22.00%762,111742,996659,337297,428
920,625-5.80%977,338954,705955,5511,326,986

流动负债
短期借款0--0000
应付票据0--0000
应付帐款85,708-2.69%88,07647,72816,06136,448
其他流动负债33,347-15.63%39,52448,46142,57748,833
119,054-6.70%127,60096,18958,63885,281
流动资产净值801,571-5.67%849,738858,516896,9131,241,705
资产总额减流动负债1,908,2550.90%1,891,3091,819,4091,751,4631,706,397

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债50,4764.12%48,48129,84118,4629,829
50,4764.12%48,48129,84118,4629,829

总权益
    实收股本263,4950.00%263,495263,495263,495175,663
    储备项目1,594,2840.95%1,579,3331,526,0731,469,5061,520,905
股东权益1,857,7790.81%1,842,8281,789,5681,733,0011,696,568
非控股权益0--0000